Group | Sample size n (good prog + poor prog) | Nested CV AUROCC performance | Feature list (high expression → poor prognosis) | Feature list (high expression → good prognosis) |
---|---|---|---|---|
All patient | 146 (68+78) | 0.73 (0.04) | BIRC5, CCNB2, CENPA, TK1, CCNE2, DKFZp762E1312, PRC1, STK15, SLC16A3, BUB1 | CEGP1, SLC11A3, C4A, ZNF145, MATN3, PGR, RAI2, DLX2 |
ER+ | 107 (57+50) | 0.76 (0.05) | H1F2, COX6C, H2BFB, CCNE2, BLVRB | FST, DIO3, NTN4, DLX2, MATN3, COL3A1 |
Node+ | 64 (30+34) | 0.80 (0.06) | H1F2, H2BFB, HA2FO, H2AFA, HABFB, KFZp762E1312, H2BFS | LTF, NTN4, HML2, PER1, DMBT1, ODZ2, WNT5A, SEMA3C |
Node- | 82 (38+44) | 0.72 (0.06) | PRAME, FADSD6, TK1, TSSC3, CTSL2, BUB1 | CEGP1, ESR1, CYP4B1, SEC14L2, TBX3-iso, ZNF145 |
ER+/Node+ | 50 (26+24) | 0.83 (0.06) | H1F2, H2BFB, H2AFP, H2AFA, H2BFB, COX6C, MSMB, BLVRB, , BCAS1 | LTF, LAMB3, C4A, NTN4, PTPRK, RTN1 |